✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Akums Drugs & Pharmaceuticals Ltd.

AKUMS

Market Cap
₹9,596 Cr.
P/E
37.60

Akums Drugs & Pharmaceuticals Ltd.

  • Akums Drugs & Pharma
  • Strides Pharma Scien
  • Medplus Health Serv.

FAQs on Akums Drugs & Pharmaceuticals Ltd. Shareprice

Akums Drugs & Pharma has given better returns compared to its competitors.
Akums Drugs & Pharma has grown at ~2.58% over the last 1yrs while peers have grown at a median rate of -1.0%

Akums Drugs & Pharma is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Akums Drugs & Pharma is 37.6, while 3 year average PE is 14.68.
Also latest EV/EBITDA of Akums Drugs & Pharma is 15.3 while 3yr average is 17.97.

View FAQ's On Business

Growth Table

  • Akums Drugs & Pharmaceuticals Ltd.
  • Strides Pharma Scien
  • Medplus Health Serv.

Balance Sheet

  • Akums Drugs & Pharmaceuticals Ltd.
  • Strides Pharma Scien
  • Medplus Health Serv.

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Akums Drugs & Pharmaceuticals Ltd.
  • Strides Pharma Scien
  • Medplus Health Serv.

Cash Flow

  • Akums Drugs & Pharmaceuticals Ltd.
  • Strides Pharma Scien
  • Medplus Health Serv.

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Akums Drugs & Pharmaceuticals Ltd.
  • Strides Pharma Scien
  • Medplus Health Serv.

Quarterly Results

  • Akums Drugs & Pharmaceuticals Ltd.
  • Strides Pharma Scien
  • Medplus Health Serv.

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Akums Drugs & Pharmaceuticals Ltd. Financials

Balance sheet of Akums Drugs & Pharma is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Akums Drugs & Pharma is decreasing.
Latest net debt of Akums Drugs & Pharma is -₹3,287.55 Crs as of Mar-26.
This is less than Mar-25 when it was -₹1,138.75 Crs.

The profit is oscillating.
The profit of Akums Drugs & Pharma is ₹255 Crs for Mar 2026, ₹338 Crs for Mar 2025 and -₹4.04 Crs for Mar 2024

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Akums Drugs & Pharma latest dividend payout ratio is 18.0% and 3yr average dividend payout ratio is 18.0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech